MX2020008913A - Metodo para reducir el escatol y/o indol en animales. - Google Patents

Metodo para reducir el escatol y/o indol en animales.

Info

Publication number
MX2020008913A
MX2020008913A MX2020008913A MX2020008913A MX2020008913A MX 2020008913 A MX2020008913 A MX 2020008913A MX 2020008913 A MX2020008913 A MX 2020008913A MX 2020008913 A MX2020008913 A MX 2020008913A MX 2020008913 A MX2020008913 A MX 2020008913A
Authority
MX
Mexico
Prior art keywords
indole
reducing
animals
skatole
animal
Prior art date
Application number
MX2020008913A
Other languages
English (en)
Inventor
Ryouichi Moki
Eigo Sakamoto
Takeshi Yamaguchi
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of MX2020008913A publication Critical patent/MX2020008913A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invención se refiere, entre otras cosas, a un método para reducir la concentración de escatol y/o indol en un animal, que comprende administrar a dicho animal una cantidad eficaz de una composición inmunógena que comprende el antígeno de Lawsonia intracellularis. Por lo tanto, la presente invención también se refiere a métodos para reducir o el olor a cerdo o el olor a verraco.
MX2020008913A 2018-02-28 2019-02-25 Metodo para reducir el escatol y/o indol en animales. MX2020008913A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18159151 2018-02-28
PCT/EP2019/054570 WO2019166362A1 (en) 2018-02-28 2019-02-25 Method for reducing skatole and/or indole in animals

Publications (1)

Publication Number Publication Date
MX2020008913A true MX2020008913A (es) 2020-10-01

Family

ID=61557049

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020008913A MX2020008913A (es) 2018-02-28 2019-02-25 Metodo para reducir el escatol y/o indol en animales.

Country Status (11)

Country Link
US (1) US10792352B2 (es)
EP (1) EP3758740A1 (es)
JP (1) JP7139437B2 (es)
KR (1) KR20200127003A (es)
CN (1) CN111757752B (es)
AU (1) AU2019228294A1 (es)
BR (1) BR112020017520A2 (es)
CA (1) CA3088651A1 (es)
EA (1) EA202091994A1 (es)
MX (1) MX2020008913A (es)
WO (1) WO2019166362A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102477054B1 (ko) * 2020-03-24 2022-12-14 주식회사 바이오앱 웅취 제거용 재조합 단백질 및 이를 포함하는 백신 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
US5885823A (en) 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
BR9611623A (pt) 1995-11-30 1999-12-28 Daratech Pty Ltd Composição de vacina e processo para a profilaxia ou tratamento de infecção em um animal ou pássaro por lawsonia intracelularis ou microorganismo relacionado, molécula de ácido nucleico isolada, e, vacina genética.
US5905923A (en) 1998-02-02 1999-05-18 Sensormatic Electronics Corporation Video camera mounting assembly with friction bearings for inhibiting pan and tilt movements
CA2423588A1 (en) 2000-09-29 2002-04-04 Arizona Board Of Regents On Behalf Of The University Of Arizona Improved vaccines for proliferative ileitis and methods of making and using the same
US20060240077A1 (en) * 2003-03-25 2006-10-26 Hansen Laurits L Methodologies for improving the quality of meat, health status of animals and impact on environment
PL1651260T5 (pl) 2003-07-25 2018-11-30 Boehringer Ingelheim Vetmedica, Inc. Lawsonia intracellularis pochodzenia europejskiego oraz szczepionki, środki diagnostyczne i sposoby ją wykorzystujące
US7550270B2 (en) * 2004-08-13 2009-06-23 Boehringer Ingelheim Vetmedica, Inc. Ileitis diagnostic assay
US8398994B2 (en) 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
WO2009006466A1 (en) * 2007-07-02 2009-01-08 Novus International Inc. Feeding regime for prevention of porcine enteropathic conditions
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
US20140017268A1 (en) * 2012-06-05 2014-01-16 Regents Of The University Of Minnesota Composition and Methods for Detecting or Preventing Lawsonia intracellularis Infections
EP2789346A1 (en) * 2013-04-11 2014-10-15 CEVA Santé Animale SA Fusion polypeptides and vaccines

Also Published As

Publication number Publication date
CN111757752B (zh) 2024-08-09
AU2019228294A1 (en) 2020-08-13
EA202091994A1 (ru) 2020-12-25
CN111757752A (zh) 2020-10-09
US20190358310A1 (en) 2019-11-28
KR20200127003A (ko) 2020-11-09
JP7139437B2 (ja) 2022-09-20
WO2019166362A1 (en) 2019-09-06
EP3758740A1 (en) 2021-01-06
JP2021517559A (ja) 2021-07-26
US10792352B2 (en) 2020-10-06
CA3088651A1 (en) 2019-09-06
BR112020017520A2 (pt) 2020-12-22

Similar Documents

Publication Publication Date Title
UA104129C2 (ru) Уменьшение сопутствующих инфекций у свиней с помощью антигена pcv2
MX2019001903A (es) Composiciones y metodos para modular la microflora gastrointestinal en un canino.
CR7742A (es) Formulaciones para uso veterinario que contienen productos de origen no animal
MX2017005721A (es) Composicion veterinaria masticable agradable al paladar.
UA103298C2 (ru) Способ лечения молодых свиней с помощью антигена pcv2
UA100507C2 (ru) Предупреждение и лечение субклинической формы болезней, вызываемых цирковирусом свиней (pcvd)
ECSP11010975A (es) Método de uso de una cepa de bacillus subtilis para mejorar la salud de animales
BR112015025803A2 (pt) método para tratar um substrato animal
MX2008013619A (es) Aumento del titulo para vacunacion en animales.
MX2019007349A (es) Vacuna combinada para cerdos.
AR096671A1 (es) Método para preparar una composición de aditivos para alimento para animales
UA100502C2 (ru) Лечение prdc с применением антигена pcv2
BR112012015960A2 (pt) Composições incluindo piruvato para animais de companhia e métodos de uso destas.
AR077611A1 (es) Metodo y conjunto de elementos ( kit) para tratar la adiccion a la nicotina. combinacion. uso.
MX2018006961A (es) Hidratacion para animales.
MX2017004662A (es) Composiciones y metodos para mejorar la movilidad o actividad o tratar la fragilidad.
EA201990227A1 (ru) Композиции и способы повышения выживаемости и темпов роста домашнего скота
CO2020016266A2 (es) Compuestos orgánicos
EA202090563A1 (ru) Анти-pacap антитело
MY191905A (en) M hyo multivalent vaccine and uses thereof
MX2020008913A (es) Metodo para reducir el escatol y/o indol en animales.
BR112021020777A2 (pt) Vacina de subunidade do csfv
EA201401202A1 (ru) ВАКЦИНАЦИЯ РЕСПИРАТОРНЫМ КОРОНАВИРУСОМ СОБАК ДЛЯ ЗАЩИТЫ ОТ ИНФЕКЦИЙ B.Bronchiseptica
MX2017006638A (es) Metodos y composiciones para el incremento de la masa corporal magra y minimizar la ganancia de grasa corporal y el control del peso.
MX2020010243A (es) Composiciones bucales y metodos para animales.